Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

  1. Alonso, C.
  2. Satta, V.
  3. Hernández-Fisac, I.
  4. Fernández-Ruiz, J.
  5. Sagredo, O.
Revue:
Neuropharmacology

ISSN: 1873-7064,  0028-3908

Année de publication: 2023

Volumen: 237

Type: Article

DOI: 10.1016/J.NEUROPHARM.2023.109602 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus